information, please contact Dr Laura Hinze, hinze.laura@mh-hannover.de , phone (0511) 532-7880. A video in which MHH President Professor Dr. Michael Manns visits Dr. Laura Hinze's laboratory and talks to her [...] 07 December 2021 As one of the youngest female doctors ever, Dr. Laura Hinze has been honoured by the German Cancer Aid in the Max Eder Junior Research Group Programme. The 24-year-old doctor and researcher [...] for the promotion of young scientists at MHH," says MHH President Professor Dr. Michael Manns. "Laura Hinze is an exceptional talent. Actually, she was still too young to take part in the funding programme
SERVICE: For more information, contact Dr Laura Hinze, hinze.laura@mh-hannover.de . A video of MHH President Professor Dr Michael Manns visiting Dr Laura Hinze's lab and talking to her about her research [...] 25.01.2022 Dr Laura Hinze, a doctor and researcher at Hannover Medical School (MHH), will be awarded the Paul Ehrlich and Ludwig Darmstaedter Young Investigator Prize 2022 in March, the Paul Ehrlich Foundation [...] "This is a great honour for Ms Hinze and a wonderful success for our promotion of young researchers," emphasises MHH President Professor Dr Michael Manns. For Dr Hinze, it is already the second major
Working group PD Dr. Laura Hinze Molecular mechanisms of chemotherapy resistance in cancer cells Copyright: Karin Kaiser / MHH PD Dr. med. Laura Hinze Research Group Leader Hannover Medical School Center [...] Hematology and Oncology OE 6780, Carl-Neuberg-Str. 1, 30625 Hanover Phone: +49 511 532 7880 E-mail: hinze.laura @ mh-hannover.de Research focus Our research group investigates the molecular mechanisms of ch
Dr. Laura Hinze working group Members of the working group Dr. Laura Hinze Büsra Cinar, M. Sc. PhD student HBRS "Molecular Medicine" Copyright: Marie Heiduczek Tim Dolgner PhD student Dr. rer. nat. Beate
links to the page of the Pediatric Registry for Stem Cell Transplants and Cell Therapies Dr. med. Laura Hinze working group Main areas of research Molecular mechanisms of chemotherapy resistance in cancer [...] targets Molecular mechanisms of clonal heterogeneity Further links to the project page AG Dr. Laura Hinze Prof. Dr. med. Britta Maecker-Kolhoff working group Main areas of research Lymphoproliferative
Awards are nothing new for Dr Laura Hinze. In 2021, at the age of 24, she was one of the youngest female doctors ever to receive an award from German Cancer Aid in the Max Eder Junior Research Group Programme [...] her the Science Prize "for outstanding scientific achievements in the field of cancer research". Dr Hinze will invest the prize money of 30,000 euros in a new fluorescence microscope. She hopes to use it
ed myocardial tissues Tim Dolgner GERMANY; Tim.Dolgner @ stud.mh-hannover.de Supervisors: Dr. Laura Hinze/ Prof. Dr. Christian Kratz (Pediatric Hematology and Oncology) Project: Decoding mechanisms of [...] Hematology) Project: Novel approaches to generate tailored anticancer immunotherapies Laura Trumann GERMANY; Trumann.Laura @ mh-hannover.de Supervisor: Prof. Dr. Thomas Thum (Fraunhofer ITEM and IMTTS) Project: [...] monocytic cells Francis Nkansah Forbi GHANA, Forbi.Francis @ mh-hannover.de Supervisors: Dr. Christian Hinze/ Prof. Dr. Kai Schmidt-Ott (Nephrology) Project: Unraveling molecular mechanisms of septic acute kidney
advance adoptive T-cell therapy Tanima Dey , INDIA, Dey.Tanima @ mh-hannover.de Supervisor: PD Dr. Laura Hinze (Pediatric Hematology) Project: Targeting Ubiquitin Ligases to interfere with adaptive proteasomal [...] (CORAT-Ts) Aigerim Kabulova , KAZACHSTAN, Kabulova.Aigerim @ mh-hannover.de Supervisor: PD Dr. Christian Hinze (Nephrology) Project: Molecular investigation of calcineurin Inhibitor-induced kidney injury Girish
Click here for the video Young scientists Prof. Dr. Michael Manns visits the laboratory of Dr. Laura Hinze The 24-year-old physician and researcher wants to prevent standard therapies from not working for
Khalida Ibrahim MALAYSIA Ibrahim.Nurul @ mh-hannover.de Supervisors: Prof. Dr. Martin Stanulla / Laura Hinze (Pediatric Hematology & Oncology) Project: Deciphering the molecular regulation of Wnt/STOP in